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Toll-like receptors (TLRs) constitute an im-
portant family of innate immune receptors that 
recognize pathogen-associated molecular pat-
terns, evolutionarily conserved structures re-
quired for microbial fi  tness that are absent or 
underrepresented in the host (1, 2). We previ-
ously demonstrated that TLR5 recognizes bac-
terial fl  agellin (3), the most abundant protein 
found in the whip-like structures that propel 
bacteria (4). We defi  ned fl  agellin as a prototyp-
ical pathogen-associated molecular pattern by 
identifying the 13 amino acids on fl  agellin that 
are involved in TLR5 recognition (5). The 
TLR5 recognition site on fl  agellin is located on 
the convex surface of the fl  agellin monomer 
that contacts adjacent monomers when they 
stack in the fl  agellar fi  lament. TLR5 is acti-
vated by fl  agellins from a wide variety of bac-
teria, with the exception of two clades of 
fl  agellated bacteria possessing unusual fl  agellin 
sequences that permit TLR5 evasion while 
preserving bacterial motility (6).
In contrast to the well-defi  ned TLR5 re-
cognition site on fl  agellin, the complementary 
region on TLR5 that interacts with fl  agellin 
has not been established. TLRs are type I inte-
gral membrane glycoproteins with a series of 
19–25 tandem leucine-rich repeat (LRR) mo-
tifs in the extracellular domain, each of which 
is 24–29 amino acids in length (7). Multiple 
LRR proteins have been crystallized and have 
been shown to form curved solenoid struc-
tures, but until recently no TLR structure had 
been solved. In 2005, the structure of the 
TLR3 extracellular domain was determined by 
two groups (8, 9) who demonstrated that the 
LRR of TLR3 also forms a curved solenoid. A 
recent study has suggested that the lateral, glycan-
free surface of TLR3 recognizes double-
stranded RNA (10).
Because TLR5 recognizes a protein ago-
nist, a detailed molecular analysis of its inter-
action with fl  agellin is tractable. Two groups 
previously attempted to defi  ne this interaction 
but produced confl   icting results, and neither 
group took into consideration the three-di-
mensional structure of TLR5 (11, 12). In the 
present study, we construct a model of TLR5 
based on other LRR proteins. We exploit dif-
ferences in fl  agellin recognition between hu-
man and mouse TLR5 to defi  ne a conserved 
surface on the concave β sheets of TLR5 that 
is responsible for fl  agellin recognition. These 
data provide detailed molecular analysis of a 
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TLR–agonist interaction and suggest general rules for TLR/
ligand recognition that may guide future studies in this 
  important area.
RESULTS
Mouse TLR5 detects most fl  agellins better 
than human TLR5
We expressed epitope-tagged human or mouse TLR5 and 
NF-κB luciferase reporter constructs in CHO-K1 cells, and 
similar TLR5 expression levels were detected in the two 
  stably transfected populations (Fig. 1 A). We purifi  ed fl  agel-
lin from Salmonella typhimurium, Escherichia coli, Pseudomonas 
aeruginosa, Listeria monocytogenes, and Serratia marcescens and tested 
the ability of each fl  agellin to stimulate either human or 
mouse TLR5. Mouse TLR5 detected S. typhimurium, E. coli, 
P. aeruginosa, and L. monocytogenes fl  agellins at lower doses 
than human TLR5 (Fig. 1, B–E). These diff  erences could not 
be explained by variability in receptor expression or signal-
ing, as human TLR5 recognized S. marcescens fl  agellin better 
than mouse TLR5 (Fig. 1 F). The eff  ective concentrations of 
fl  agellin that elicit 50% maximal response (EC50) for human 
and mouse TLR5 are listed in Fig. 1 G.
The TLR5 extracellular domain is responsible 
for fl  agellin recognition
In our previous study in which we identifi  ed the TLR5 rec-
ognition site on fl  agellin, we generated and characterized ala-
nine point mutants of Salmonella fl  agellin (5). One mutant in 
Figure 1.  Mouse TLR5 detects most fl  agellins better than human 
TLR5. (A) Immunoblot of CHO cells stably expressing vector alone or 
  human (h) or mouse (m) TLR5. 100 μg of cellular cytoplasmic extracts 
were loaded per lane, and TLR5 expression was detected by immuno-
blotting for the HA epitope tag. Equal loading was verifi  ed by immuno-
blotting for β-tubulin. Kilodalton values are shown. (B–F) Shown is the 
percent fold induction of NF-κB luciferase activity for fl  agellin purifi  ed 
from each indicated bacterial species relative to maximal stimulation 
achieved with S. typhimurium fl  agellin for cells expressing either human 
(continuous line) or mouse (dashed line) TLR5 at the indicated fl  agellin 
doses. Data are representative of at least three independent experiments. 
Error bars represent the mean ± SD. (G) Table listing the effective fl  agellin 
concentrations needed to achieve half maximal activation of TLR5 (EC50). 
p-values were calculated using a two-tailed Student’s t test.JEM VOL. 204, February 19, 2007  395
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particular, I411A, showed the greatest reduction in recogni-
tion by human TLR5 (5). In comparison with wild-type 
  fl  agellin, I411A showed an  20-fold increase in EC50 for 
both human and mouse TLR5 (Fig. 2, A and B; and   Table I). 
In contrast, mutation of an arginine residue centrally located 
within the TLR5 recognition site, R90A, aff  ected recogni-
tion by human TLR5 (13-fold increase in EC50) but not by 
mouse TLR5 (Fig. 2, A and B; and Table I). Interestingly, 
combining both point mutations in fl  agellin, R90A/I411A, 
completely restored recognition by mouse TLR5 to wild-
type Salmonella fl  agellin levels but failed to restore recogni-
tion by human TLR5 (16-fold reduction in EC50; Fig. 2, A 
and B; and Table I). Thus, mouse TLR5, like human TLR5 
(5), discriminates between fl  agellin molecules that diff  er by 
only a single amino acid in the previously defi  ned TLR5 
  recognition site. These fl  agellin point mutants provided a tool 
to investigate species-specifi  c TLR5 recognition of bacte-
rial fl  agellin.
To determine whether fl  agellin recognition was local-
ized to the extracellular domain of TLR5, we constructed 
epitope-tagged chimeric human and mouse TLR5 molecules 
by swapping the extracellular domains (Fig. 2 C). When sta-
bly transfected, both chimeric constructs were expressed in 
CHO cells at levels similar to those observed for the parental 
constructs (Fig. 2 D). We tested the chimeric TLR5 mole-
cules for recognition of the wild-type form and point mu-
tants of Salmonella fl  agellin and found that recognition was 
dictated by the extracellular domain (Fig. 2, E and F; 
and Table I).
The central 228 amino acids of the TLR5 extracellular 
domain confer species-specifi  c fl  agellin recognition
To identify the region of the TLR5 extracellular domain that 
confers species-specifi  c recognition of fl  agellin, we aligned 
available TLR5 sequences (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20061400/DC1). TLR5 resi-
dues that vary among diff  erent species are scattered through-
out the extracellular LRR domain, and we found no single 
region that was an obvious candidate for species-specifi  c 
  recognition. We therefore made a series of chimeric human 
Figure 2.  The extracellular domain of TLR5 is responsible for fl  ag-
ellin recognition. (A and B) Dose-response curves of CHO cells trans-
fected with human (A) and mouse (B) TLR5 to wild-type fl  agellin from 
S. typhimurium, point mutants I411A and R90A, and the double mutant 
R90A/I411A. Fold induction is relative to the maximal induction seen for 
wild-type fl  agellin. (C) Table showing a linear schematic of TLR5, with 
mouse TLR5 amino acid numbers of the domain boundaries shown above 
the molecule. EC, extracellular domain; TM, transmembrane domain; TIR, 
Toll/IL-1 receptor domain. (D) Immunoblot of CHO cells stably expressing 
human (h) and mouse (m) TLR5 or the extracellular domain TLR5 chimeras 
(hm and mh). 100 μg of cellular cytoplasmic extracts were loaded per 
lane, and TLR5 expression was detected by immunoblotting for the HA 
epitope tag. Equal loading was verifi  ed by immunoblotting for β-tubulin. 
Kilodalton values are shown. (E and F) Dose-response curves of the hm 
(E) and mh (F) chimeric TLR5 receptors to wild-type flagellin from 
S. typhimurium, point mutants R90A and I411A, and the double mutant 
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and mouse TLR5 constructs and expressed these chimeras in 
CHO cells (Fig. 3, A and B).
We fi  rst tested the TLR5 chimeras containing the largest 
swap for recognition of the wild-type and mutated forms of 
Salmonella fl   agellin. The chimera containing central and 
membrane-proximal portions of the mouse TLR5 extracel-
lular domain (hmh) showed a pattern of recognition similar 
to full-length mouse TLR5 (compare Fig. 3 C with Fig. 2 B). 
Conversely, the chimera containing the central and mem-
brane-proximal portions of human TLR5 (mhh) showed a 
pattern of recognition similar to the parental human TLR5, 
with recognition of the double mutant resembling that of 
I411A (compare Fig. 3 D with Fig. 2 A). EC50 values for each 
fl  agellin detected by the chimeras are listed in Table I.
To determine whether the central (residues 174–401) or 
membrane-proximal (residues 402–637) portion of the extra-
cellular domain was responsible for species-specifi  c fl  agellin 
recognition, we made additional chimeras in which these 
two domains were swapped. A TLR5 chimera containing 
the central portion of mouse TLR5 (mmhm) showed re-
duced recognition of all point mutants, but recognition of 
the double mutant was equivalent to R90A, a pattern resem-
bling mouse TLR5 (compare Fig. 3 F with Fig. 2 B). In con-
trast, recognition of the fl  agellin point mutants by the chimera 
containing only the central portion of the human TLR5 ex-
tracellular domain (mhmm) closely resembled that of the pa-
rental full-length human TLR5 (compare Fig. 3 E with Fig. 
2 A). EC50 values for each fl  agellin detected by the chimeras 
are listed in Table I.
To test whether the decreased recognition of wild-type 
fl  agellin and the fl  agellin mutants refl  ected decreased associa-
tion of the TLR5 constructs with fl  agellin, we performed 
coprecipitations of the chimeric TLR5 receptors with wild-
type fl  agellin or the R90A fl  agellin mutant. Wild-type fl  agel-
lin precipitated human TLR5 more effi   ciently than the R90A 
fl  agellin mutant, whereas wild-type and R90A fl  agellins pre-
cipitated mouse TLR5 equivalently (Fig. 3 G). Thus, the pat-
tern of coprecipitation paralleled the dose-response data, 
suggesting that the dose-response data refl  ect fl  agellin’s asso-
ciation with TLR5. The pattern of coprecipitation also paral-
leled the dose-response curves for the chimeric receptors: 
receptors in which the EC50 for the wild type and the R90A 
mutant were similar showed equivalent precipitation by both 
fl  agellins, whereas receptors with reduced recognition of 
R90A showed reduced precipitation by R90A relative to 
wild-type fl  agellin (Fig. 3 G). Control precipitation studies 
demonstrated that the interaction between fl  agellin  and 
TLR5 was specifi  c, because precipitations with wild-type fl  a-
gellin failed to pull down TLR2 (5), and biotinylated ovalbu-
min did not precipitate TLR5 (not depicted).
Our chimera studies demonstrated that the central 228 
amino acids of the TLR5 extracellular domain (residues 174–
401) were responsible for species-specifi  c fl  agellin recog-
nition. We next sought to identify specifi   c amino acids 
responsible for human and mouse TLR5 discrimination of 
fl  agellin molecules.
Modeling of TLR5
Because the crystal structure of TLR5 has not yet been 
solved, we modeled the structure of the mouse and human 
TLR5 ectodomains based on known structures of other 
LRR proteins. Using consensus fold recognition, the best 
Table I.  EC50 values for human and mouse chimeric TLR5 molecules stimulated with wild-type and mutant fl  agellins
aSchematic of chimeric TLR5 molecules with amino acid numbers corresponding to mouse TLR5.
bEC50 values and standard deviations are listed in ng/ml, and values were calculated from at least three independent experiments, each run in duplicate.
cEC50 values for each fl  agellin point mutant were compared to wild-type fl  agellin, and p-values were calculated using a two-tailed Student’s t test. p-values >0.05 are not 
shown.
dThe pattern of response for each TLR5 chimera to the mutant fl  agellins was compared to parental human and mouse TLR5, and the overall fl  agellin recognition phenotype is 
listed.JEM VOL. 204, February 19, 2007  397
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match was determined to be L. monocytogenes internalin A 
(PDB 1o6s). Modeling of LRR-containing proteins is inher-
ently diffi   cult (13), with the resulting overall global structure 
varying considerably with even small changes in individual 
LRR or with relative orientations of adjacent LRR. We 
evaluated several models (generated by varying method pa-
rameters), which resulted in solenoids of diff  erent  global 
structure but largely uniform local structure. The  model 
of the mouse TLR5 ectodomain (amino acids 52–615) 
that we present (Fig. 4 A, left) conforms well to ideal peptide 
Figure 3.  The central 228 amino acids of the TLR5 extracellular 
domain confer species-specifi  c fl  agellin recognition. (A) Table show-
ing a linear schematic of TLR5, with amino acid numbers of the domain 
boundaries shown above the molecule. EC, extracellular domain; TM, 
transmembrane domain; TIR, Toll/IL-1 receptor domain. (B) Immunoblot of 
CHO cells stably expressing human (h) and mouse (m) TLR5 or the extra-
cellular domain TLR5 chimeras (hmh, mhh, mhmm, and mmhm). 100 μg 
of cellular cytoplasmic extracts were loaded per lane, and TLR5 expression 
was detected by immunoblotting for the HA epitope tag. Equivalent load-
ing was verifi  ed by immunoblotting for β-tubulin. Kilodalton values are 
shown. (C–F) Dose-response curves of the hmh (C), mhh (D), mmhm (E), 
and mhmm (F) chimeric TLR5 receptors to wild-type fl  agellin from 
S. typhimurium, point mutants R90A and I411A, and the double mutant 
R90A/I411A. The percent fold induction is relative to the maximal induction 
seen for wild-type fl  agellin. (G) Immunoprecipitation of chimeric TLR5 
molecules with the wild type or the R90A fl  agellin mutant.398  A SURFACE ON TOLL-LIKE RECEPTOR 5 RECOGNIZES FLAGELLIN | Andersen-Nissen et al.
and protein geometry while also generating an overall fold 
suited to binding large macromolecular ligands such as fl  a-
gellin (Fig. 4 A, right). The model was further validated by its 
similarity to the recently deposited structure of the extracel-
lular domain of TLR3 (PDB 1ziw). The real value of the 
TLR5 model was not in its high resolution atomic details but 
in guiding selection of residues for further study based on 
proximity to conserved surface residues in the TLR5 model. 
We identifi  ed amino acids that were similar among at least 
90% of vertebrate TLR5 sequences and highlighted their po-
sitions on our structural model (Fig. 4 B, green). This analysis 
revealed two regions that were conserved among all species: 
an apparent concavity located on the inner surface of the so-
lenoid structure predicted for the TLR5 ectodomain and a 
patch located on the lateral face of the molecule (Fig. 4 B). 
Both the concavity and the lateral patch were contained 
within the central 228–amino acid region that confers species-
specifi  c fl  agellin recognition.
TLR5 residue 268 imparts species-specifi  c recognition 
of fl  agellin point mutants
We hypothesized that either the conserved concavity or the 
lateral patch was the fl  agellin recognition site on TLR5, and 
that species-specifi  c TLR5 sequence diff  erences adjacent to 
one of these regions were responsible for diff  erences in fl  agel-
lin recognition by human and mouse TLR5. Several amino 
acids that diff  ered between mouse and human TLR5 clustered 
around the concavity and were good candidates for amino 
acid changes that mediate species-specifi  c TLR5 recognition 
(Fig. 4 C). We mutated mouse TLR5 residues in this region 
to the corresponding human TLR5 amino acids at three sites 
surrounding the concavity: P268A and L292R/Q293H (both 
located within the central 228-residue region) and Q407P/
M408D (located in the membrane-proximal region).
The mutant mouse TLR5 molecules were expressed in 
CHO cells at levels similar to parental human and mouse 
TLR5 (Fig. 5 A). Mutating residues 407/408, which are lo-
cated in the membrane-proximal region that is not impli-
cated in species-specifi  c fl  agellin recognition, did not aff  ect 
the pattern of fl  agellin recognition (compare Fig. 5 B with 
Fig. 2 B; Table I). In addition, mutating central region resi-
dues 292/293 to the human sequence did not aff  ect recogni-
tion of the fl  agellin point mutants (compare Fig. 5 C with 
Fig. 2 B; Table I). In contrast, mutation of a single central re-
gion amino acid, P268A, transformed the specifi  city of mouse 
TLR5 fl  agellin recognition to the pattern seen for human 
TLR5 (compare Fig. 5 D with Fig. 2 A; Table I).
To confi  rm this result, we performed the converse muta-
tion, A268P, in human TLR5. This mutation resulted in a 
receptor with reduced recognition of all fl  agellin molecules 
Figure 4.  Model of the TLR5 extracellular domain. (A) Ribbon rep-
resentations (far left and far right) and molecular surface representations 
(middle left and middle right) of the best model of the TLR5 ectodomain 
(left) and the structure of fl  agellin (PDB lucu; right). The ribbon is colored 
sequentially from the N terminus (blue) to the C terminus (red). Amino 
acids important for fl  agellin recognition are shown on the TLR5 model in 
red. Amino acids on fl  agellin previously determined to be important for 
TLR5 recognition are shown in red on the fl  agellin structure (reference 5). 
(B) Ribbon representations (left) and molecular surface representations 
(middle and right) of the best model of the TLR5 ectodomain, oriented 
 90° to the view in A. Views 180° apart are shown in the top and bottom 
rows. The ribbon is colored sequentially from the N terminus (blue) to the 
C terminus. Molecular surface representations are colored by conserva-
tion (center: residues ≥90% similar among TLR5 sequences are green) or 
by electrostatic potential (right: positive, blue; negative, red). The con-
served concavity and lateral patch regions are indicated with a dotted 
white oval and bracket, respectively. Positions of residues important for 
fl  agellin recognition are indicated with arrows. (C) Space-fi  lling represen-
tation of the TLR5 model. Residues of the conserved concavity (white) 
and residues that differ between human and mouse TLR5 in the central 
228–amino acid region, as well as 407 and 408 (red), are highlighted. 
Amino acids surrounding the concavity that were mutated are indicated 
with arrows.JEM VOL. 204, February 19, 2007  399
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(Fig. 5 E). Notably, the human TLR5 A268P receptor rec-
ognized the R90A/I411A double mutant as effi   ciently as the 
R90A single mutant and better than the I411A point mutant 
(Fig. 5 E).
These results suggest that residue 268 determines, at least 
in part, species-specifi  c fl  agellin recognition by TLR5. P268 
is adjacent to the conserved concavity in our TLR5 model 
(Fig. 4 C), which suggested that this surface may interact 
with the TLR5 recognition site on fl  agellin (5, 6).
TLR5 residues within the conserved concavity contribute 
to fl  agellin recognition
The concavity consists of 11 conserved and surface-exposed 
amino acids in our model (Fig. S1). We selected three of these 
conserved residues and mutated each one to alanine to deter-
mine their role in fl  agellin recognition. The three TLR5 ala-
nine mutants were stably expressed in CHO cells (Fig. 6 A). 
D295A showed a second, sharper band of lower molecular 
mass in addition to a band of equal molecular mass to the 
other TLR5 proteins, suggesting that the D295A mutation 
may alter glycosylation of this protein, as has been described 
for other TLRs (14–17). We tested the TLR5 alanine point 
mutants for recognition of wild-type Salmonella fl  agellin and 
the fl  agellin mutants. Mutating TLR5 residue S297 to alanine 
had no eff  ect on fl  agellin recognition, except that it slightly 
raised the EC50 for the R90A/I411A fl  agellin double mutant 
relative to parental mouse TLR5 (Fig. 6, B–E; and Table II). 
Mutating TLR5 residue D295 increased the EC50 for all fl  a-
gellins tested relative to parental mouse TLR5, suggesting that 
this residue is important for fl  agellin recognition (Fig. 6, B–E; 
and Table II). In contrast, mutating TLR5 residue D367 to 
  alanine only slightly reduced recognition of wild-type fl  agellin 
but greatly decreased recognition of the R90A, I411A, and 
R90A/I411A fl  agellin mutants. Thus, mutating TLR5 residue 
Figure 5.  P268 confers species-specifi  c recognition of fl  agellin 
point mutants. (A) Immunoblot of CHO cells stably expressing human (h) 
and mouse (m) TLR5 or the extracellular domain TLR5 mutants (mQ407P/
M408D, mL292R/Q293H, mP268A, or hA268P). 100 μg of cellular cyto-
plasmic extracts were loaded per lane, and TLR5 expression was detected 
by immunoblotting for the HA epitope tag. Equal loading was verifi  ed by 
immunoblotting for β-tubulin. Kilodalton values are shown. (B–E) Dose-
response curves of the mQ407P/M408D (B), mL292R/Q293H (C), mP268A 
(D), and hA268P (E) mutant TLR5 receptors to wild-type fl  agellin from 
S. typhimurium, point mutants R90A and I411A, and the double mutant 
R90A/I411A.400  A SURFACE ON TOLL-LIKE RECEPTOR 5 RECOGNIZES FLAGELLIN | Andersen-Nissen et al.
367 specifi  cally weakens the recognition of fl  agellins mutated in 
residues R90 and I411 as compared with wild-type fl  agellin; 
such nonadditive eff  ects further argue for a direct molecular 
interaction between TLR5 and fl  agellin (Fig. 6, B–E; and 
  Table II). Because fl  agellin residue I411 is largely buried beneath 
the TLR5 recognition site, the contribution of I411 is most 
likely indirect and may be transmitted through R90 (6). The 
locations of TLR5 residues D295 and D367, which are pre-
dicted to interact with fl  agellin, are shown on our model (Fig. 4).
D  I  S  C  U  S  S  I  O  N 
Species-specifi  c diff  erences in TLR agonist recognition have 
previously been reported for other TLRs. Human but not 
mouse TLR2 can discriminate between tripalmitoylated and 
trilauroylated peptides (18). The lipid A analogues, lipid IVa 
and Rhodobacter sphaeroides lipid A, are potent LPS antagonists 
to human TLR4 yet act as agonists for hamster TLR4 (19, 20). 
Human TLR4 also distinguishes between P . aeruginosa penta- 
and hexaacylated lipid A structures, whereas mouse TLR4 
cannot (21). Finally, mouse and human TLR9 have been 
shown to recognize distinct synthetic CpG motifs (22). 
Our fi  ndings for TLR5 parallel these previous studies, but the 
biological signifi  cance of diff  erential fl  agellin recognition by 
mouse and human TLR5 remains unknown. Species prefer-
ences for certain fl  agellin molecules by TLRs may have arisen 
through the long evolutionary history of host–pathogen 
  interactions (23) and may refl  ect host adaptation to patho-
genic and commensal bacteria, as well as selective pressures on 
bacteria to establish niches within hosts.
In this study, we identify three TLR5 residues, P268, 
D295, and D367, that are important for fl  agellin recognition 
and thus provide further evidence for a direct interaction be-
tween fl  agellin and TLR5. Because proline residues often af-
fect the local structure of the polypeptide chain, the P268A 
mutation may infl  uence  fl   agellin recognition indirectly. 
TLR5 residues D295/D367 and fl  agellin R90, however, are 
surface exposed and may form salt bridges or other polar in-
teractions. This possibility is supported by the fact that polar–
polar and charge–polar interactions account for the majority 
of molecular contacts between adjacent monomers in the fl  a-
gellar fi  lament, and a subset of these residues also forms the 
TLR5 recognition site on fl  agellin (24).
Two previous reports have addressed the region of TLR5 
that mediates fl   agellin recognition. One study, comprised 
Figure 6.  The conserved concavity on TLR5 interacts with fl  agellin. 
(A) Immunoblot of CHO cells stably expressing mouse TLR5 (m) or the 
TLR5 concavity point mutants (mD295A, mS297A, and mD367A). 100 μg 
of cellular cytoplasmic extracts were loaded per lane, and TLR5 expression 
was detected by immunoblotting for the HA epitope tag. Equal loading 
was verifi  ed by immunoblotting for β-tubulin. Kilodalton values are 
shown. (B–E) Dose-response curves for wild-type fl  agellin (B) from 
S. typhimurium and fl  agellin point mutants R90A (C), I411A (D), and 
R90A/I411A (E) for each TLR5 point mutant.JEM VOL. 204, February 19, 2007  401
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solely of theoretical modeling, hypothesized that human 
TLR5 residues 552–560 were responsible for fl  agellin recog-
nition (11). This region is outside of the central 228 amino 
acids that contain the conserved concavity and patch, and 
there is no experimental data to support the 552–560 region 
in fl  agellin recognition. In addition, an examination of the 
TLR5 sequence alignment reveals that fi  ve amino acids in 
this nine amino acid stretch vary among TLR5 sequences, 
implying that only a subset of these amino acids could have 
been involved in the interaction with fl  agellin. A second re-
port used coimmunoprecipitation studies to conclude that 
human TLR5 residues 386–407 (mouse TLR5 386–406 in 
our sequence; Fig. S1) were responsible for fl  agellin binding 
(12). Residues 386–401 of this block are located within the 
central 228 stretch; however, none of these amino acids con-
tribute to the conserved concavity and lateral patch and only 
9 out of 16 amino acids in this block are >90% conserved 
among vertebrates. In addition to the lack of sequence con-
servation in the regions defi  ned by these two studies, the 
possibility that a linear stretch of amino acids (composing at 
most a single LRR) could be solely responsible for fl  agellin 
recognition is not well supported by our structural model and 
the recent TLR3 structures (8, 9). Our modeling and muta-
genesis studies of TLR5 have led to the hypothesis that the 
highly conserved concavity on TLR5 formed by β sheets on 
one face of the LRR structure serves as the fl  agellin recogni-
tion site, which is distinct from the 386–407 and 552–561 
regions previously implicated in fl  agellin recognition.
Our model of TLR5 resembles the recently determined 
TLR3 structure (8, 9), with some strong similarities of par-
ticular note. The conserved lateral patch we identifi  ed on 
TLR5 is located on the same lateral face of the molecule as 
the nonglycosylated face of TLR3. This surface on TLR3 
off  ers the largest area for intermolecular interactions and con-
tains the site of the dimer interface observed in the TLR3 
crystals (8, 9). We therefore hypothesize that the conserved 
lateral patch on TLR5 is involved in TLR5 dimerization. 
Several candidate binding sites for double-stranded RNA 
were identifi  ed on the TLR3 structure, one being the con-
cave surface of the solenoid (9) that is analogous to the con-
served concavity on TLR5. Indeed, the concave surface of 
the solenoid is a common site of ligand binding for multiple 
LRR proteins, including molecules such as ribonuclease in-
hibitor (25), internalin A (26), and platelet glycoprotein Ibα 
(27). A recent mutational analysis of TLR3 reported that 
double-stranded RNA binds TLR3 on the lateral glycan-free 
surface of the molecule (10). This study used size-exclusion 
chromatography to demonstrate that two TLR3 point 
  mutants no longer formed high molecular mass aggregates 
with polyI:C. These TLR3 amino acid residues may infl  u-
ence ligand-dependent oligomerization either through direct 
interactions with polyI:C or by infl  uencing receptor–receptor 
interactions.
The similarities between our data for TLR5 recognition 
of fl  agellin and structural models of TLR3 recognition of 
double-stranded RNA (9) suggest a common mechanism for 
agonist recognition by TLRs, where the TLR agonist binds 
to the concave surface of the solenoid and thereby infl  uences 
receptor dimerization and/or signaling. Flagellin binding to 
the TLR5 concavity could induce receptor signaling through 
several mechanisms. TLR5 may be expressed as a dimer, as 
suggested by the crystal structure of TLR3 (8, 9), and binding 
of fl  agellin may induce a conformational change in the recep-
tor, resulting in productive signaling. Alternatively, binding 
of fl  agellin to a single TLR5 molecule may induce a confor-
mational change that allows dimerization with other fl  agel-
lin-bound TLR5 molecules, as occurs with the epidermal 
growth factor receptor (28). Yet another possibility is that 
one fl   agellin monomer may bind two TLR5 molecules, 
which would require TLR5 to recognize two distinct sites 
on fl  agellin, as occurs with binding of human growth hor-
mone to its receptor (29). These questions will only be re-
solved through more detailed biochemical and structural 
analyses of TLR/agonist recognition. Our current results 
  defi   ne the likely TLR5–fl   agellin interaction interface and 
suggest general rules for TLR–ligand interactions, providing 
an important step toward the rational design of therapeu-
tic interventions.
MATERIALS AND METHODS
Cell lines and bacterial strains. CHO-K1 cells (American Type Culture 
Collection) were grown in Ham’s F-12 medium supplemented with 
penicillin, streptomycin, l-glutamine, and 10% cosmic calf serum (Hy-
Clone). The following bacteria were grown overnight, shaking in Luria-
Bertani: S. typhimurium strain TH4778 (FljB−/FliC+; a gift from K. Hughes, 
Table II.  EC50 values for alanine point-mutant mouse chimeric TLR5 molecules stimulated with wild-type and mutant fl  agellins
aSchematic of alanine point-mutant mouse TLR5 molecules.
bEC50 values and standard deviations are listed in ng/ml, and values were calculated from at least three independent experiments, each run in duplicate.
cEC50 values for each TLR5 construct were compared to parental TLR5, and p-values were calculated using a two-tailed Student’s t test. p-values >0.05 are not shown.402  A SURFACE ON TOLL-LIKE RECEPTOR 5 RECOGNIZES FLAGELLIN | Andersen-Nissen et al.
University of Washington, Seattle, WA), E. coli, clinical isolate H9049 
(University of Washington), P. aeruginosa strain PAK (a gift from D. Speert, 
University of British Columbia, Vancouver, Canada), and L. monocytogenes 
strain 10403 (a gift from D. Portnoy, University of California, San Francisco, 
San Francisco, CA). S. marcescens (clinical isolate; University of Washington, 
Seattle, WA) was grown on Luria-Bertani agar plates.
NF-κB luciferase reporter assays. CHO-K1 cells were electroporated 
with hemagglutinin (HA)-tagged TLR5 cDNA cloned into the pEFIN 
vector (the pEF6 V5/His TOPO vector [Invitrogen] with an IRES-Neo 
fragment cloned into the NotI-XbaI sites) and ELAM-LUC (30) plasmids, 
and selected with neomycin. Stable populations were stimulated for 4 h and 
assayed for luciferase activity using an assay system (Luciferase 1000; Pro-
mega). All assays were done in duplicate, and each experiment was repeated 
at least three times. The percent fold induction was calculated by dividing 
the luciferase values for the test fl  agellins by the luciferase value for the wild-
type Salmonella fl  agellin.
CHO-K1 cell cytoplasmic extracts and TLR5 immunoblots. 
  Approximately 107 CHO cells expressing either pEFIN alone or pEFIN TLR5 
constructs were lifted with PBS containing 1mM EDTA, 1mM dithiothrei-
tol, and protease inhibitors (cocktail set 1; Calbiochem). Cytoplasmic 
  extracts  were prepared by washing cells with hypotonic buff  er  solution 
(10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol, 
and protease inhibitors) and resuspending in hypotonic buff  er solution for 
10 min on ice. NP-40 was added to a fi  nal concentration of 0.2%, and nuclei 
were removed by centrifuging at 3,300 g for 15 min. Protein concentrations 
were determined using the DC Protein Assay (Bio-Rad Laboratories), and 
100 μg of each cytoplasmic extract was run on an SDS-PAGE gel. HA-
tagged TLR5 proteins were detected by immunoblotting with mouse 
anti-HA1.1 ascites (Covance) and horseradish peroxidase–conjugated rabbit 
anti–mouse (Zymed Laboratories). Loading controls for each immunoblot 
were detected using mouse anti–β tubulin (Sigma-Aldrich) and horseradish 
peroxidase -conjugated rabbit anti–mouse (Zymed Laboratories).
Purifi  cation of native bacterial fl  agellin. S. typhimurium, E. coli, P. aeruginosa, 
L. monocytogenes, and S. marcescens were grown overnight and pelleted by 
centrifugation. Cell pellets were washed once in PBS, resuspended in PBS, 
and sheared for 2 min at high speed in a Waring blender. The sheared 
  suspension was centrifuged for 10 min at 8,000 g, and the supernatant was 
collected and centrifuged at 100,000 g for 1 h to pellet fl  agellar fi  laments. 
Filaments were resuspended in PBS at 4°C overnight and centrifuged at 
100,000 g for 1 h. This wash step was repeated twice. The resulting pellet of 
washed fl  agellar fi  laments was resuspended in PBS and heated to 70°C for 
20 min to depolymerize filaments into flagellin monomers. Protein con-
centration was determined using the BCA assay (Pierce Chemical CO.), and 
purity was confi  rmed by SDS-PAGE and Coomassie blue staining.
Creation and purifi  cation of alanine point mutant fl  agellins. The fl i C  
gene, which encodes fl  agellin, was cloned into the NcoI and HindIII sites of 
ptrc99a plasmid. Single amino acid mutations were made using a standard 
PCR mutagenesis strategy (31). All mutations were verifi  ed by DNA sequenc-
ing. The mutant plasmids were transformed into the BC696 (fl j B −/fl i C −) 
strain of S. typhimurium SL1344 (5), and fl  agellin was purifi  ed as for the na-
tive fl  agellin described in the previous section, without the fi  nal wash steps.
Coprecipitation studies. Wild-type or R90A fl  agellins were biotinylated 
with EZ-Link Sulfo-NHS-LC-Biotin (Pierce Chemical Co.) and dialyzed 
against PBS. CHO cells stably expressing HA-tagged TLR5 constructs were 
lysed in 20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, and 0.5% NP-40, 
pH 7.5. Nuclei were cleared by 5 min of centrifugation at 3,000 g. Cleared 
lysate was incubated with 10 μg/ml biotinylated fl  agellin for 30 min at 4°C, 
followed by incubation with streptavidin sepharose (GE Healthcare) for 30 
min at 4°C. Beads were washed with PBS, and proteins were eluted by boil-
ing in SDS-PAGE loading buff  er. Equivalent cell portions of the immuno-
precipitation were separated by SDS-PAGE, and TLR5 was immunoblotted 
using mouse anti-HA1.1, as described in CHO-K1 cell cytoplasmic extracts 
and TLR5 immunoblots.
TLR5 sequence alignments. TLR5 sequences from the following species 
were used in the TLR5 sequence alignment and are available from Gen-
Bank/EMBL/DDBJ under the indicated accession numbers: Rattus norvegicus 
(rat, XP_223016), Mus musculus (mouse, Q9JLF7), Homo sapiens (human, 
NP_003259), Canis familiaris (dog [23]), Monodelphis domestica (opossum [23]), 
Xenopus laevis (African clawed frog, AAH84773), Takifugu rubripes (puff  erfi  sh, 
AAW69374), Oncorhynchus mykiss (trout, BAD38860), Gallus gallus (chicken, 
AF186107), and Sus scrofa (pig, BAD91800). TLR5 sequences were 
aligned  using ClustalW (http://www.ch.embnet.org/software/ClustalW.
html) and displayed with Boxshade (http://www.ch.embnet.org/software/
BOX_form.html).
Modeling of TLR5. Models for TLR5 were generated using consensus 
fold recognition. Alignments were detected to multiple proteins using three-
dimensional jury (which found good hits via ORFeus and FFAS) (32, 33). 
These alignments to multiple proteins were used to make a complete model 
using Rosetta (34, 35) via the Robetta server (http://robetta.bakerlab.org/). 
Locally, this model is of high accuracy, and error in this model is likely con-
centrated near the N and C termini of the protein, where errors in the mod-
eling of long loops can cause register shifts with respect to the repeat 
structure. Models were analyzed and fi  gures were prepared with PyMOL 
(DeLano Scientifi   c LLC) and Protein Explorer (http://www.umass.edu/
microbio/chime/pe/protexpl/frntdoor.htm).
Online supplemental material. Fig. S1 shows a sequence alignment of 
the central 228 amino acids of TLR5′s extracellular domain determined to 
be important for flagellin recognition. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20061400/DC1.
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